Literature DB >> 31178071

Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.

Gleice Cristina Leite1, Richard A Stabler2, Patrícia Neves1, Lauro V Perdigão Neto1, Roberta C Ruedas Martins1, Camila Rizek3, Flavia Rossi4, Anna S Levin5, Silvia Figueiredo Costa6.   

Abstract

Treatment of infections caused by A. baumannii is becoming a challenge due to the ability to develop multidrug-resistance, virulence, and high mortality. We described the colistin resistance and virulence genes present in sixA. baumannii clinical isolates using WGS, expression by qPCR, and virulence in the Galleria mellonella model. The colistin-resistant isolates were assigned as ST233 and the colistin-susceptible isolates as ST236 and ST407. The colistin-resistant isolates contained mutations within PmrA/PmrB, and the pmrA showed up-regulation in all of them. Only one colistin-resistant isolate indicating virulence in G. mellonella. This particular isolate belonged to a different clone, and it was the only isolate that presented non-synonymous mutations in pmrB. Colistinresistance in A. baumannii isolates seems to be caused by up-regulation of pmrA gene. Only one isolate appeared to be virulent in the G. mellonella model. This finding indicating low virulence in isolates belonging to emerging clones circulating in our hospital.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Galleria mellonella; colistin-resistant; resistance; virulence; whole-sequencing

Mesh:

Substances:

Year:  2019        PMID: 31178071     DOI: 10.1016/j.diagmicrobio.2019.04.013

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  1 in total

1.  Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America.

Authors:  Carolina Silva Nodari; Rodrigo Cayô; Ana Paula Streling; Felipe Lei; Julia Wille; Myriam S Almeida; Alexandre Inacio de Paula; Antonio Carlos Campos Pignatari; Harald Seifert; Paul G Higgins; Ana Cristina Gales
Journal:  Front Microbiol       Date:  2020-11-30       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.